ロード中...
Assessment of 24,25(OH)2D levels does not support FGF23-mediated catabolism of vitamin D metabolites
Progressive elevations of fibroblastic growth factor 23 [FGF23] in chronic kidney disease may reduce serum 25-hydroxyvitamin D [25(OH)] and 1,25-dihydroxyvitamin D [1,25(OH)2D] levels, via stimulation of 24-hydroxylase (Cyp24A1) mediated catabolism of these vitamin D metabolites. To test this possib...
保存先:
| 主要な著者: | , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3461248/ https://ncbi.nlm.nih.gov/pubmed/22739976 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ki.2012.222 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|